AbbVie presents applications to FDA and EMA for approval of SKYRIZI in psoriatic arthritis

Psoriatic arthritis is a heterogeneous, systemic inflammatory disease with characteristic manifestations across multiple parts of the body including joints and skin. Credit: Steven HWG/Unsplash.